North Bud Farms Inc. (NOBDF) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 18, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerNorth Bud Farms Inc. (NOBDF) trades at $0.00001. North Bud Farms Inc. focuses on producing pharmaceutical-grade cannabis and food-grade cannabinoid-infused inputs. The company targets both the pharmaceutical and recreational cannabis markets in Canada. Sector: Healthcare.
Price as of · Last analyzed: Mar 18, 2026Analyst Coverage for NOBDF: NOBDF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
North Bud Farms Inc. (NOBDF) Healthcare & Pipeline Overview
North Bud Farms Inc. is a Canadian company focused on the production of pharmaceutical-grade cannabis and cannabinoid-infused inputs for both pharmaceutical and recreational markets. Incorporated in 2016, the company aims to capitalize on the growing cannabis sector in Canada, facing competition from established players and evolving regulations.
What Is the Investment Thesis for NOBDF?
Investing in North Bud Farms Inc. presents a high-risk, high-reward scenario. The company operates in the rapidly growing Canadian cannabis market, offering potential for significant revenue growth. However, the company's small market capitalization ($0.00B) and negative P/E ratio (-0.00) indicate financial instability. Key value drivers include successful product development, regulatory approvals, and market penetration. Growth catalysts include the expansion of the Canadian cannabis market and potential partnerships with established pharmaceutical companies. Potential risks include intense competition, evolving regulations, and the company's ability to secure funding for expansion. Due to the OTC market and limited financial information, investors should proceed with caution.
Based on FMP financials and quantitative analysis
NOBDF Key Highlights
North Bud Farms Inc. focuses on the production of pharmaceutical-grade cannabis and food-grade cannabinoid-infused inputs.
- The company targets both the pharmaceutical and recreational cannabis markets in Canada.
- Incorporated in 2016, North Bud Farms is a relatively young company in the cannabis industry.
- The company's market capitalization is $0.00B, indicating a small market presence.
- North Bud Farms operates with a negative P/E ratio of -0.00, reflecting current financial challenges.
Who Are NOBDF's Competitors?
NOBDF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| BIOVF Swedish Orphan Biovitrum AB (publ) | $42.90 | 0.00% | $16.4B | — |
| ESAIY Eisai Co., Ltd. | $7.41 | -0.54% | $8.37B | — |
| GIFLF Grifols, S.A. | $11.13 | 0.00% | $7.57B | — |
| AKAN Akanda Corp. | $1.91 | -3.54% | — | |
| APUS Apimeds Pharmaceuticals US, Inc. | $4.59 | +42.55% | $6.93M | — |
| BFRI Biofrontera Inc. | $0.89 | -12.23% | $11.4M | — |
| COSM COSM | $0.35 | -9.03% | $18.8M | — |
| QNTM Quantum BioPharma Ltd. | $3.27 | -4.94% | $20.9M | — |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are NOBDF's Key Strengths?
Focus on pharmaceutical-grade cannabis.
- Production of cannabinoid-infused inputs.
- Early mover advantage in the Canadian market.
- Potential for strategic partnerships.
What Are NOBDF's Weaknesses?
Small market capitalization.
- Negative P/E ratio.
- Limited financial resources.
- Dependence on the Canadian market.
What Are the Key Risks for NOBDF?
Financial-distress signal — its Altman Z-Score of -1.17 sits in the distress zone (elevated bankruptcy risk).
- Negative return on equity (-27.0%) — the business is not currently generating profit on shareholder capital.
- Weak fundamentals — a Piotroski F-Score of 1/9 flags soft profitability, leverage or efficiency.
- Intense competition from established cannabis producers.
- Evolving regulations and changes in cannabis laws.
- Fluctuations in cannabis prices.
- Difficulty securing funding for expansion.
- Limited financial disclosure due to OTC listing.
What Are NOBDF's Competitive Advantages?
- Focus on pharmaceutical-grade cannabis production.
- Development of food-grade cannabinoid-infused inputs.
- Strategic partnerships within the cannabis industry.
- Early mover advantage in the Canadian cannabis market.
What Does NOBDF Do?
North Bud Farms Inc., established in 2016 and headquartered in Toronto, Canada, operates in the burgeoning cannabis industry. The company's core business revolves around the production of pharmaceutical-grade cannabis and food-grade cannabinoid-infused inputs. These products are intended for use in both the pharmaceutical and recreational cannabis markets within Canada. North Bud Farms aims to serve as a supplier of high-quality cannabis and cannabis-derived ingredients, catering to businesses that manufacture cannabis-based products. The company's strategy involves adhering to strict quality control standards to meet the requirements of the pharmaceutical sector while also addressing the growing demand for cannabinoid-infused products in the recreational market. As a relatively young company in a rapidly evolving industry, North Bud Farms is focused on establishing its market presence and building relationships with key players in the Canadian cannabis landscape. The company's success will depend on its ability to navigate the complex regulatory environment, maintain product quality, and effectively compete with larger and more established companies.
What Products and Services Does NOBDF Offer?
- Produces pharmaceutical-grade cannabis.
- Develops food-grade cannabinoid-infused inputs.
- Supplies cannabis products to the pharmaceutical market.
- Supplies cannabis products to the recreational market.
- Focuses on the Canadian cannabis market.
- Aims to meet strict quality control standards.
How Does NOBDF Make Money?
- Production and sale of pharmaceutical-grade cannabis.
- Production and sale of food-grade cannabinoid-infused inputs.
- Partnerships with pharmaceutical and recreational cannabis companies.
What Industry Does NOBDF Operate In?
North Bud Farms Inc. operates within the rapidly expanding Canadian cannabis industry. The market is characterized by increasing demand for both recreational and medicinal cannabis products. The industry is also subject to evolving regulations and intense competition. North Bud Farms competes with established cannabis producers and pharmaceutical companies. The Canadian cannabis market is projected to continue growing, driven by increasing acceptance and legalization. The company's success depends on its ability to differentiate its products, navigate the regulatory landscape, and secure market share.
Who Are NOBDF's Key Customers?
- Pharmaceutical companies manufacturing cannabis-based drugs.
- Recreational cannabis companies producing infused products.
- Consumers seeking pharmaceutical-grade cannabis products.
- Businesses requiring cannabinoid-infused inputs for their products.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● No usable price
- ● No filing on record
- ● No analyst coverage
Financial Health
North Bud Farms Inc.'s Piotroski F-Score is 1/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -1.17 places it in the distress zone, a signal of elevated financial risk.
Key Financial Metrics
Return on equity for North Bud Farms Inc. stands at -27.0%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -23.5%, showing how much profit it generates from its asset base. A current ratio of 4.48 indicates the company holds enough short-term assets to cover its near-term obligations.
Company Profile
North Bud Farms Inc. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Toronto, CA. The company is led by CEO Ryan Brown. NOBDF has traded publicly since 2018.
NOBDF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
NOBDF Latest News
No recent news available for NOBDF.
NOBDF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for NOBDF.
Price Targets
Wall Street price target analysis for NOBDF.
NOBDF MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for NOBDF; grades run from A+ (80-100) to F (below 30).
Leadership: Ryan Brown
CEO
Ryan Brown serves as the CEO of North Bud Farms Inc. Further research would be required to provide a comprehensive profile of his professional experience and credentials.
Track Record: Due to the limited information available, it is not possible to assess Ryan Brown's track record at North Bud Farms Inc. or in previous roles. Key achievements, strategic decisions, and company milestones under his leadership cannot be determined without additional data.
NOBDF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that North Bud Farms Inc. may not meet the minimum financial reporting standards required for higher tiers like OTCQB or OTCQX. Companies in this tier may have limited or no financial disclosure, making it difficult for investors to assess their financial health and operational performance. Investing in companies on the OTC Other tier carries a higher degree of risk due to the lack of transparency and regulatory oversight compared to companies listed on major exchanges like the NYSE or NASDAQ.
- OTC Tier: OTC Other
- Limited financial disclosure.
- Low liquidity and wide bid-ask spreads.
- Potential for price manipulation.
- Higher risk of fraud or scams.
- Lack of regulatory oversight.
- Verify the company's registration and legal status.
- Review available financial statements and disclosures.
- Assess the company's business model and competitive landscape.
- Research the company's management team and their track record.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor before investing.
- Check for any regulatory actions or legal issues.
- Company's registration with regulatory bodies.
- Existence of a physical office or operational facilities.
- Presence of a professional website and investor relations materials.
- Positive news coverage or industry recognition.
- Active engagement with shareholders and the investment community.
North Bud Farms Inc. Healthcare Stock: Key Questions Answered
What do analysts say about NOBDF stock?
Due to the company's OTC listing and limited financial information, analyst coverage of NOBDF stock is likely minimal or non-existent. Key valuation metrics, such as price targets and earnings estimates, are unavailable. Investors should conduct their own thorough due diligence and consider the risks associated with investing in OTC stocks.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Limited information available on North Bud Farms Inc.
- OTC listing increases investment risk.
- Financial data may be incomplete or unaudited.